Literature DB >> 15240623

Usefulness of homeostasis model assessment for identifying subjects at risk for hypoglycemia failure during the insulin hypoglycemia test.

Gemma Francisco1, Cristina Hernández, Rosa Galard, Rafael Simó.   

Abstract

One of the main problems of the insulin hypoglycemia test (IHT) is the failure to achieve an adequate hypoglycemia (blood glucose, <45 mg/dl) with the standard dose of insulin used. The aim of the study was to identify by means of homeostasis model assessment (HOMA) the subjects at risk for hypoglycemia failure during IHT. For this purpose 32 patients in whom an IHT was performed were prospectively included. Receiver operating characteristics curve analyses were performed to assess the sensitivity and specificity of both insulinemia and HOMA. Eight patients (25%) did not reach adequate hypoglycemia. A serum insulin concentration above 17.7 microIU/ml or a HOMA value above 4.38 identified those subjects who would not reach adequate hypoglycemia with a probability of 75%. By contrast, when the levels of either insulinemia or HOMA were lower than the cut-off points mentioned above, the probability that individuals would reach sufficient hypoglycemia was 89.5%. In conclusion, quantitative estimate of insulin resistance by HOMA is a simple and reliable method that permits identification of individuals at risk of not reaching adequate hypoglycemia during IHT. In these patients, either alternative tests or a higher dose of insulin should be considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240623     DOI: 10.1210/jc.2003-031883

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence.

Authors:  Jun Chen; Houwei Li; Francesco Addabbo; Fung Zhang; Edward Pelger; Daniel Patschan; Hyeong-Cheon Park; Mei-Chuan Kuo; Jei Ni; Glenda Gobe; Praveen N Chander; Alberto Nasjletti; Michael S Goligorsky
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

2.  Revisiting peak serum cortisol response to insulin-induced hypoglycemia in children.

Authors:  J B Drummond; B S Soares; W Pedrosa; A Ribeiro-Oliveira
Journal:  J Endocrinol Invest       Date:  2020-09-21       Impact factor: 4.256

3.  Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Authors:  Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.